Researchers have created a platform, called SIMPL2, that revolutionizes the study of protein-protein interactions by simplifying detection while improving measurement accuracy. While protein-protein interactions have previously been considered ‘undruggable’ using small molecules, the platform addresses this challenge by facilitating the measurement of these interactions — improving our understanding of the types of molecules needed to control them.
Researchers develop tool to fast-track measurement of protein interactions for drug discovery
